These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 16472938

  • 1. Modeling radiation dosimetry to predict cognitive outcomes in pediatric patients with CNS embryonal tumors including medulloblastoma.
    Merchant TE, Kiehna EN, Li C, Shukla H, Sengupta S, Xiong X, Gajjar A, Mulhern RK.
    Int J Radiat Oncol Biol Phys; 2006 May 01; 65(1):210-21. PubMed ID: 16472938
    [Abstract] [Full Text] [Related]

  • 2. Necrosis after craniospinal irradiation: results from a prospective series of children with central nervous system embryonal tumors.
    Murphy ES, Merchant TE, Wu S, Xiong X, Lukose R, Wright KD, Qaddoumi I, Armstrong GT, Broniscer A, Gajjar A.
    Int J Radiat Oncol Biol Phys; 2012 Aug 01; 83(5):e655-60. PubMed ID: 22768993
    [Abstract] [Full Text] [Related]

  • 3. Radiation dosimetry predicts IQ after conformal radiation therapy in pediatric patients with localized ependymoma.
    Merchant TE, Kiehna EN, Li C, Xiong X, Mulhern RK.
    Int J Radiat Oncol Biol Phys; 2005 Dec 01; 63(5):1546-54. PubMed ID: 16115736
    [Abstract] [Full Text] [Related]

  • 4. Critical combinations of radiation dose and volume predict intelligence quotient and academic achievement scores after craniospinal irradiation in children with medulloblastoma.
    Merchant TE, Schreiber JE, Wu S, Lukose R, Xiong X, Gajjar A.
    Int J Radiat Oncol Biol Phys; 2014 Nov 01; 90(3):554-61. PubMed ID: 25160611
    [Abstract] [Full Text] [Related]

  • 5. Proton radiation therapy for pediatric medulloblastoma and supratentorial primitive neuroectodermal tumors: outcomes for very young children treated with upfront chemotherapy.
    Jimenez RB, Sethi R, Depauw N, Pulsifer MB, Adams J, McBride SM, Ebb D, Fullerton BC, Tarbell NJ, Yock TI, Macdonald SM.
    Int J Radiat Oncol Biol Phys; 2013 Sep 01; 87(1):120-6. PubMed ID: 23790826
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.
    Yasuda K, Taguchi H, Sawamura Y, Ikeda J, Aoyama H, Fujieda K, Ishii N, Kashiwamura M, Iwasaki Y, Shirato H.
    Jpn J Clin Oncol; 2008 Jul 01; 38(7):486-92. PubMed ID: 18573848
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Activity of postoperative carboplatin, etoposide, and high-dose methotrexate in pediatric CNS embryonal tumors: results of a phase II study in newly diagnosed children.
    Kellie SJ, Wong CK, Pozza LD, Waters KD, Lockwood L, Mauger DC, White L.
    Med Pediatr Oncol; 2002 Sep 01; 39(3):168-74. PubMed ID: 12210445
    [Abstract] [Full Text] [Related]

  • 11. Early Cognitive Outcomes Following Proton Radiation in Pediatric Patients With Brain and Central Nervous System Tumors.
    Pulsifer MB, Sethi RV, Kuhlthau KA, MacDonald SM, Tarbell NJ, Yock TI.
    Int J Radiat Oncol Biol Phys; 2015 Oct 01; 93(2):400-7. PubMed ID: 26254679
    [Abstract] [Full Text] [Related]

  • 12. Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study.
    Ris MD, Packer R, Goldwein J, Jones-Wallace D, Boyett JM.
    J Clin Oncol; 2001 Aug 01; 19(15):3470-6. PubMed ID: 11481352
    [Abstract] [Full Text] [Related]

  • 13. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.
    Merchant TE, Kun LE, Krasin MJ, Wallace D, Chintagumpala MM, Woo SY, Ashley DM, Sexton M, Kellie SJ, Ahern V, Gajjar A.
    Int J Radiat Oncol Biol Phys; 2008 Mar 01; 70(3):782-7. PubMed ID: 17892918
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Survival and neurocognitive outcomes after cranial or craniospinal irradiation plus total-body irradiation before stem cell transplantation in pediatric leukemia patients with central nervous system involvement.
    Hiniker SM, Agarwal R, Modlin LA, Gray CC, Harris JP, Million L, Kiamanesh EF, Donaldson SS.
    Int J Radiat Oncol Biol Phys; 2014 May 01; 89(1):67-74. PubMed ID: 24725690
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Intensity-modulated and 3D-conformal radiotherapy for whole-ventricular irradiation as compared with conventional whole-brain irradiation in the management of localized central nervous system germ cell tumors.
    Chen MJ, Santos Ada S, Sakuraba RK, Lopes CP, Gonçalves VD, Weltman E, Ferrigno R, Cruz JC.
    Int J Radiat Oncol Biol Phys; 2010 Feb 01; 76(2):608-14. PubMed ID: 19879065
    [Abstract] [Full Text] [Related]

  • 20. Factors influencing neurocognitive outcomes in young patients with benign and low-grade brain tumors treated with stereotactic conformal radiotherapy.
    Jalali R, Mallick I, Dutta D, Goswami S, Gupta T, Munshi A, Deshpande D, Sarin R.
    Int J Radiat Oncol Biol Phys; 2010 Jul 15; 77(4):974-9. PubMed ID: 19864079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.